The warning comes as South Africa continues to strengthen its response to foot-and-mouth disease (FMD).
Novonesis has not disclosed an expected closing date.
The company will usethe funding to increase production capacity and accelerate the commercialization of its precision-fermented dairy proteins.
The deal is expected to accelerate the global deployment of TARGAN’s hatchery automation and biodevice solutions.
The transaction includes the first and only European commercial vaccine against swine dysentery caused by Brachyspira H.
Probiotic-based solutions highlight swine production as a key sector where microbial technologies can support both animal nutrition and waste management.
The trial reduced greenhouse gas emissions by approximately 29.8 tonnes of CO₂ equivalent over the study period.
The collaboration brings together Symrise’s global pet food ingredients portfolio and Bond Pet Foods’ fermentation platform to support next-generation protein innovation in the sector.